EXPANSION ADDS STATE-OF-THE-ART UPSTREAM AND DOWNSTREAM GMP PROCESSING CAPABILITIES TO MEET THE GROWING DEMAND FOR 2,000 ...
WuXi Biologics and Sinorda Biomedicine collaborate to accelerate development and manufacturing of innovative bispecific antibody: Shanghai Friday, January 30, 2026, 10:00 Hrs [IST ...
WuXi Biologics and Sinorda Biomedicine have jointly announced a strategic collaboration for the development and manufacturing of SND006.
News Medical on MSN
WuXi Biologics and Hanchorbio enter strategic partnership to advance next-generation bi- and multi-functional fusion protein pipeline
WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio Inc., a global clinical-stage biotechnology company advancing next-generation ...
Creative Diagnostics announces the release of a specialized portfolio of Antibiotic Residue Detection ELISA Kits. NEW ...
Bora Biologics just gave San Diego's biotech scene a serious flex, cutting the ribbon on a $30 million expansion of its FDA-registered manufacturing campus in Sorrento Valley. The upgrade adds ...
News-Medical.Net on MSN
JPM highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO platform delivering sustainable high growth
On January 14, Dr. Chris Chen, CEO of WuXi Biologics, delivered a keynote at the 44th J.P. Morgan Healthcare Conference, ...
HENDERSON, NV AND LAS VEGAS, NV / ACCESS Newswire / September 30, 2025 / Precision Biologics Manufacturing, a New Horizon Medical Solutions (NHMS) company, announced a groundbreaking for its ...
DUBLIN--(BUSINESS WIRE)--The "Biologics Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System ...
Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results